Advertisements
Year

Kobayashi, Daiki

Tokyo Medical University, Japan

2023 Rank: 506528

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

General & Internal Medicine

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 5565 out of 321279 Researchers

Data For The Year: 2023
Metrics Self-Citations Excluded All
Rank Based on Composite Score506528460088
Total Cites250269
H-index78
Hm-index23
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers3838
Total Cites to Single+First Authored Papers6274
Number of Single+First+Last Authored Papers5656
Total Cites to Single+First+Last Authored Papers87100
Composite Score22
Number of Distinct Citing Papers241251
Ratio of Total Citations to Distinct Citing Papers 1.04 1.07
Self-Citation Percentage
7.06%
Found an error in your data? Contact us with your profile link. Contact Us →

Kobayashi, Daiki

St. Luke's International Hospital Tokyo, Japan

2022 Rank: 565495

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

General & Internal Medicine

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 5817 out of 311132 Researchers

Data For The Year: 2022
Metrics Self-Citations Excluded All
Rank Based on Composite Score565495641124
Total Cites200214
H-index66
Hm-index22
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers3636
Total Cites to Single+First Authored Papers5056
Number of Single+First+Last Authored Papers5252
Total Cites to Single+First+Last Authored Papers6571
Composite Score22
Number of Distinct Citing Papers200211
Ratio of Total Citations to Distinct Citing Papers 1.00 1.01
Self-Citation Percentage
6.54%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements